ElevenLabs’ $300M Tender Doubles Its Valuation to $22B—but It Wasn’t a Funding Round

ElevenLabs’ $300 million tender offer did not mean the company raised $300 million in a new funding round. Employees and other existing shareholders sold shares to investors at a price implying a $22 billion valuation—twice the $11 billion valuation attached to the company’s February 2026 Series D.17 The sale gave shareholders a chance to cash out some of their holdings; it did not, by itself, add the sale proceeds to ElevenLabs’ operating funds.

How the tender offer differs from a funding round

In a primary funding round, investors buy newly issued shares and the company receives the capital, subject to the terms of the deal. In a tender offer, existing shareholders sell their shares to buyers. The $300 million figure describes the value of shares sold, while the $22 billion figure is the valuation implied by the price paid per share.

That distinction matters: the tender establishes a price at which buyers and sellers transacted, but it is not the same as a fresh $22 billion valuation set by a conventional financing round. Nor does a private-market transaction guarantee that public-market investors would value the business the same way.17

Who bought shares—and who sold

Wellington Management and T. Rowe Price led the tender. ElevenLabs said new investors in the transaction included EQT, Goldman Sachs, GIC, Ontario Teachers’ Pension Plan, Sapphire Ventures, and BDT & MSD. Existing investors also participated.

The sellers included employees and other existing shareholders. That offers some liquidity to people who hold private-company shares while allowing the company to remain private.1719

Why the valuation rose: reported growth and enterprise use

ElevenLabs builds AI voice products for speech generation, dubbing and business conversations. The company says its enterprise business now accounts for 55% of revenue and that its ElevenAgents product handles more than 15 million conversations a week.5 Reported customers include Klarna, Deutsche Telekom, Cisco and Adobe.6

The revenue figures point to fast growth, but they come from different sources and should be read with care. ElevenLabs reported more than $330 million in annual recurring revenue (ARR) at the end of 2025; a later company update put the year-end figure at $350 million and said ARR had passed $500 million in the first four months of 2026. Sacra estimates ARR reached $600 million in June.12133

ARR is a measure of recurring revenue at a given run rate, not the same thing as audited annual revenue. Using Sacra’s $600 million estimate, a $22 billion valuation is roughly 37 times ARR. That rough comparison shows how much the price depends on expectations for continued growth; it is not a measure of profit or a forecast that the company will meet those expectations.3

Competition and risks remain part of the picture

Enterprise adoption is evidence of demand, but it does not by itself show that the business is profitable or that customers will stay. Competition is already visible: TechCrunch reports that Decagon, a conversational AI company that trained its voice product on ElevenLabs, now competes with it.6

The available reporting here does not provide enough detail to assess ElevenLabs’ specific legal exposure or the likely financial effect of any legal dispute. That is a limit in the evidence, not proof that legal risks are absent. The valuation should therefore be read as a transaction price alongside unresolved questions—not as a verdict on the company’s long-term prospects.

What the tender says about a possible IPO

The tender provided private-market liquidity without requiring an IPO. ElevenLabs CEO Mati Staniszewski has described wanting the company to be ready for a listing within roughly two and a half years. That points toward a possible 2029 readiness goal, but it is an aspiration, not an announced IPO date.

Overall, the $22 billion tender price reflects buyers’ willingness to purchase shares at a much higher implied valuation, alongside the company’s reported growth and enterprise adoption. It does not establish what the business would be worth in public markets—or whether its growth can continue amid competition and risks that remain difficult to assess from the available reporting.5617